471 related articles for article (PubMed ID: 15802211)
1. Life-threatening acute adverse cutaneous drug reactions.
Wolf R; Orion E; Marcos B; Matz H
Clin Dermatol; 2005; 23(2):171-81. PubMed ID: 15802211
[TBL] [Abstract][Full Text] [Related]
2. [Cutaneous reactions to drugs].
Mulder WM; Meinardi MM; Bruynzeel DP
Ned Tijdschr Geneeskd; 2004 Feb; 148(9):415-20. PubMed ID: 15038200
[TBL] [Abstract][Full Text] [Related]
3. Drug rash with eosinophilia and systemic symptoms vs toxic epidermal necrolysis: the dilemma of classification.
Wolf R; Matz H; Marcos B; Orion E
Clin Dermatol; 2005; 23(3):311-4. PubMed ID: 15896547
[TBL] [Abstract][Full Text] [Related]
4. Severe cutaneous adverse reactions: acute generalized exanthematous pustulosis, toxic epidermal necrolysis and Stevens-Johnson syndrome.
Harr T; French LE
Med Clin North Am; 2010 Jul; 94(4):727-42, x. PubMed ID: 20609860
[TBL] [Abstract][Full Text] [Related]
5. Approach to the patient with a suspected drug eruption.
Cotliar J
Semin Cutan Med Surg; 2007 Sep; 26(3):147-54. PubMed ID: 18070681
[TBL] [Abstract][Full Text] [Related]
6. Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome.
Ghislain PD; Roujeau JC
Dermatol Online J; 2002 Jun; 8(1):5. PubMed ID: 12165215
[TBL] [Abstract][Full Text] [Related]
7. Serious and life-threatening drug eruptions.
Manders SM
Am Fam Physician; 1995 Jun; 51(8):1865-72. PubMed ID: 7762478
[TBL] [Abstract][Full Text] [Related]
8. Adverse cutaneous drug eruptions and HIV: a clinician's global perspective.
Todd G
Dermatol Clin; 2006 Oct; 24(4):459-72, vi. PubMed ID: 17010776
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis.
Ziemer M; Wiesend CL; Vetter R; Weiss J; Blaschke S; Norgauer J; Mockenhaupt M
Arch Dermatol; 2007 Jun; 143(6):711-6. PubMed ID: 17576936
[TBL] [Abstract][Full Text] [Related]
10. [Cutaneous side effects due to psychiatric drugs].
Rebok F; Pérez Roldán ML; Daray FM
Vertex; 2008; 19(82):348-56. PubMed ID: 19424517
[TBL] [Abstract][Full Text] [Related]
11. Recognition and management of severe cutaneous drug reactions.
Knowles SR; Shear NH
Dermatol Clin; 2007 Apr; 25(2):245-53, viii. PubMed ID: 17430761
[TBL] [Abstract][Full Text] [Related]
12. [Severe delayed drug hypersensitivity reactions].
Maniu CM; Buss G; Feldmeyer L; Spertini F; Ribi C
Rev Med Suisse; 2013 Apr; 9(382):803-4, 806-11. PubMed ID: 23667969
[TBL] [Abstract][Full Text] [Related]
13. Critical overview: adverse cutaneous reactions to psychotropic medications.
Kimyai-Asadi A; Harris JC; Nousari HC
J Clin Psychiatry; 1999 Oct; 60(10):714-25; quiz 726. PubMed ID: 10549695
[TBL] [Abstract][Full Text] [Related]
14. Phenytoin-associated hypersensitivity syndrome with features of DRESS and TEN/SJS.
Viera MH; Perez OA; Patel JK; Jones I; Berman B
Cutis; 2010 Jun; 85(6):312-7. PubMed ID: 20666193
[TBL] [Abstract][Full Text] [Related]
15. [Drug allergy].
Sueki H
Nihon Rinsho; 2009 Nov; 67(11):2139-43. PubMed ID: 19899530
[TBL] [Abstract][Full Text] [Related]
16. Severe adverse cutaneous reactions to drugs.
Roujeau JC; Stern RS
N Engl J Med; 1994 Nov; 331(19):1272-85. PubMed ID: 7794310
[No Abstract] [Full Text] [Related]
17. [Drug rash with eosinophilia and systemic symptoms (DRESS syndrome)].
Lobo I; Ferreira M; Velho G; Sanches M; Selores M
Acta Med Port; 2008; 21(4):367-72. PubMed ID: 19094812
[TBL] [Abstract][Full Text] [Related]
18. Severe cutaneous adverse drug reactions: who should treat, where and how?: Facts and controversies.
Wolf R; Davidovici B
Clin Dermatol; 2010; 28(3):344-8. PubMed ID: 20541690
[TBL] [Abstract][Full Text] [Related]
19. Hypersensitivity reactions to proton pump inhibitors.
Chang YS
Curr Opin Allergy Clin Immunol; 2012 Aug; 12(4):348-53. PubMed ID: 22744268
[TBL] [Abstract][Full Text] [Related]
20. Life-threatening dermatoses.
Cram DL
Calif Med; 1973 Feb; 118(2):5-12. PubMed ID: 4701711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
